Nath A. Association of herpes viral infections, antiherpetic therapy, and dementia: real or alternative fact? Neurotherapeutics. 2018; 15: 415–416.
Tzeng N-S, Chung CH, Lin FH et al. Antiherpetic medications and reduced risk of dementia in patients with herpes simplex virus infections – a nationwide population-based cohort study in Taiwan. Neurotherapeutics 2018; 15: 417–429.
Itzhaki RF, Lathe R. Herpes viruses and senile dementia: first population evidence for a causal link. J. Alzheimers Dis. 2018; 64: 363–366.
Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet 1997; 349: 241–244.
Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport 2003; 14: 1825–1827.
Jayasuriya AN, Itzhaki RF, Wozniak MA et al. Apolipoprotein E-epsilon 4 and recurrent genital herpes in individuals co-infected with herpes simplex virus type 2 and HIV. Sex.Transm.Infect. 2008; 84: 516–517.
Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A. APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding. Sex.Transm.Infect. 2010; 86: 202–206.
Gerard HC, Wildt KL, Whittum-Hudson JA, Lai Z, Ager J, Hudson AP. The load of Chlamydia pneumoniae in the Alzheimer’s brain varies with APOE genotype. Microb.Pathog. 2005; 39: 19–26.
Gerard HC, Wang GF, Balin BJ, Schumacher HR, Hudson AP. Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides. Microb.Pathog. 1999; 26: 35–43.
Burt TD, Agan BK, Marconi VC et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc.Natl.Acad.Sci U.S.A 2008; 105: 8718–8723.
Rathore N, Ramani SR, Pantua H et al. Paired immunoglobulin-like type 2 receptor alpha G78R variant alters ligand binding and confers protection to Alzheimer’s disease. PLoS Genet. 2018; 14: e1007427
Tsai MC, Cheng WL, Sheu JJ et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS.One. 2017; 12: e0188490.
Chen VC, Wu SI, Huang KY et al. Herpes zoster and dementia: a nationwide population-based cohort study. J.Clin.Psychiatry. 2018; 79.
Tzeng NS, Chung CH, Yeh CB et al. Are chronic periodontitis and gingivitis associated with dementia? A nationwide, retrospective, matched-cohort study in Taiwan. Neuroepidemiology. 2016; 47: 82–93.
Lee YT, Lee HC, Hu CJ et al. Periodontitis as a modifiable risk factor for dementia: a nationwide population-based cohort study. J.Am.Geriatr.Soc. 2017; 65: 301–305.
Chen CK, Wu YT, Chang YC. Association between chronic periodontitis and the risk of Alzheimer’s disease: a retrospective, population-based, matched-cohort study. Alzheimers.Res.Ther. 2017; 9: 56.
Miklossy J. Alzheimer’s disease – a neurospirochetosis Analysis of the evidence following Koch’s and Hill’s criteria. J.Neuroinflammation. 2011; 8: 90.
Gerard HC, Dreses-Werringloer U, Wildt KS et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain. FEMS Immunol.Med.Microbiol. 2006; 48: 355–366.
Xu F, Schillinger JA, Sternberg MR et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. Journal of Infectious Diseases 2002; 185: 1019–1024.
Pebody RG, Andrews N, Brown D et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex.Transm.Infect. 2004; 80: 185–191.
Shen JH, Huang KY, Chao-Yu C, Chen CJ, Lin TY, Huang YC. Seroprevalence of herpes simplex virus type 1 and 2 in Taiwan and risk factor analysis, 2007. PLoS.One. 2015; 10: e0134178.
Nicoll MP, Proenca JT, Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS.Microbiol.Rev. 2012; 36: 684–705.
Grinde B. Herpesviruses: latency and reactivation – viral strategies and host response. J.Oral.Microbiol. 2013; 5: 22766.
Baringer JR, Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N.Engl.J.Med. 1973; 288: 648–650.
Croen KD, Ostrove JM, Dragovic LJ, Smialek JE, Straus SE. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene ‘anti-sense’ transcript by in situ hybridization. N.Engl.J.Med. 1987; 317: 1427–1432.
Furuta Y, Takasu T, Sato KC, Fukuda S, Inuyama Y, Nagashima K. Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathol. 1992; 84: 39–44.
Theil D, Arbusow V, Derfuss T et al. Prevalence of HSV-1 LAT in human trigeminal, geniculate, and vestibular ganglia and its implication for cranial nerve syndromes. Brain Pathol. 2001; 11: 408–413.
Lathe R, Haas JG. Distribution of cellular HSV-1 receptor expression in human brain. J.Neurovirol. 2017; 23: 376–384.
Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains. J.Med.Virol. 1991; 33: 224–227.
Jamieson GA, Maitland NJ, Wilcock GK, Yates CM, Itzhaki RF. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J.Pathol. 1992; 167: 365–368.
Readhead B, Haure-Mirande JV, Funk CC et al. Multiscale analysis of independent Alzheimer’s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron 2018; 99: 64–82.
Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neuroscience Letters 2007; 429: 95–100.
Soscia SJ, Kirby JE, Washicosky KJ et al. The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 2010; 5: e9505.
Moir RD, Lathe R, Tanzi RE. The antimicrobial protection hypothesis of Alzheimer’s disease. Alzheimer’s and Dementia 2018. Published online October 9, 2018. https://doi.org/10.1016/j.jalz.2018.06.3040
Bourgade K, Le PA, Bocti C et al. Protective effect of amyloid-beta peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J. Alzheimers Dis. 2016; 50: 1227–1241.
Eimer WA, Kumar DKV, Shanmugam NKN et al. Alzheimer’s disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 2018; 99: 56–63.
Haas JG, Lathe R. Microbes and Alzheimer’s disease: new findings call for a paradigm change. Trends.Neurosci. 2018; 41: 570–573.
Jamieson GA, Maitland NJ, Craske J, Wilcock GK, Itzhaki RF. Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer’s disease brain using polymerase chain reaction. Biochem.Soc.Trans. 1991; 19: 122S.
Franceschi C, Salvioli S, Garagnani P, de Eguileor M, Monti D, Capri M. Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity. Front.Immunol. 2017; 8: 982.
Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp.Gerontol. 2007; 42: 563–570.
Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age. J.Med.Virol. 2012; 84: 1797–1802.
Itzhaki RF. Herpes and Alzheimer’s disease: subversion in the central nervous system and how it might be halted. J.Alzheimers.Dis. 2016; 54: 1273–1281.
Darby G, Larder BA, Bastow KF, Field HJ. Sensitivity of viruses to phosphorylated 9-(2-hydroxyethoxymethyl)guanine revealed in TK-transformed cells. Journal of General Virology 1980; 48: 451–454.
Collins P. The spectrum of antiviral activities of acyclovir in vitro and in vivo. J. Antimicrob.Chemother. 1983; 12 Suppl B: 19–27.
Ying B, Tollefson AE, Spencer JF et al. Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters. Antimicrob.Agents.Chemother. 2014; 58: 7171–7181.
McMahon MA, Siliciano JD, Lai J et al. The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J.Biol.Chem. 2008; 283: 31289–31293.
Celum C, Wald A, Lingappa JR et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N.Engl.J.Med. 2010; 362: 427–439.